Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NaQing ZhiMing Tablet
- Development stage
- Unknown
- Lead developer
- Beijing Huayi Shennong Pharmaceutical Technology
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
NaQing ZhiMing Tablet (纳清指迷片) is a Traditional Chinese Medicine (TCM) candidate developed by Beijing Huayi Shennong Pharmaceutical Technology Co., Ltd. for the treatment of mild to moderate vascular dementia. Classified as a Class 1.1 new TCM drug in China, it is specifically indicated for patients presenting with the TCM syndrome of "deficiency of kidney essence and marrow sea." The therapeutic approach is designed to improve cognitive function and provide neuroprotection. A Phase I clinical trial (CTR20201406) was conducted in healthy Chinese volunteers to evaluate the safety, tolerability, and pharmacokinetic profile of single and multiple oral doses of the tablet.
- Other names
- Naqing Zhiming TabletNaqing Zhiming Pian纳清指迷片
Beyond the preview
Go deeper on NaQing ZhiMing Tablet.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NaQing ZhiMing Tablet.